Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vital Therapies Inc (NASDAQ:VTL)

7.89
Delayed Data
As of Feb 12
 +0.40 / +5.34%
Today’s Change
2.81
Today|||52-Week Range
29.67
-31.51%
Year-to-Date
No recent news for Vital Therapies Inc.

Today’s Trading

Previous close7.49
Today’s open7.68
Day’s range6.83 - 8.31
Volume311,314
Average volume (3 months)440,825
Market cap$239.0M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-12.74%
Earnings growth (this year)+40.91%
Earnings growth (next 5 years)+10.27%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.94

Competitors

 Today’s
change
Today’s
% change
OREXOrexigen Therapeutic...-0.01-0.61%
LBIOLion Biotechnologies...+0.36+7.81%
VSARVersartis Inc+0.21+2.63%
ZGNXZogenix Inc+0.27+2.84%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 17, 2016
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$0.00
Annual profit (last year)-$47.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Co-Chairman &
Chief Executive Officer
Terence E. Winters
Chief Financial Officer &
Treasurer
Michael V. Swanson
Corporate headquarters
San Diego, California

Forecasts

Partner Offers